Dr. Daniel F. Kawano

Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

Email: [email protected]

Qualifications

2010 Ph.D., University of São Paulo, Faculty of Pharmaceutical Sciences at Ribeirão Preto, Brazil, Medicinal Chemistry

2006 M.Sc., University of São Paulo, Faculty of Pharmaceutical Sciences at Ribeirão Preto, Brazil, Pharmaceutical Sciences

2002 B.Sc., University of São Paulo, Faculty of Pharmaceutical Sciences at Ribeirão Preto, Brazil, Pharmacy

Publications(selected)

1. Kawano D. F., Carvalho I. (2013) Targeting Trypanosoma cruzi platelet-activating factor receptors: scope for the development of novel drugs to treat Chagas disease. Mini-Rev. Med. Chem. 13:997-1004.
2. Pinsetta F. R., Kawano D. F., Carvalho M. R., Oliveira J. A. A., Corrado A. P., Hyppolito M. A., Carvalho I. (2013) Synthesis of neamine-based pseudodisaccharides as potential vestibulotoxic agents to treat vertigo in Ménière s disease. Carbohydr. Res. 373:97-102.
3. Kawano D. F., Silva V. B., Jorge D. M. M., Silva C. H. T. P., Carvalho I. (2011) Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 106:957-67.
4. Silva V. B., Andrade P., Kawano D. F., Morais P. A. B., Almeida J. R., Carvalho I., Taft C. A., Silva C. H. T. P. (2011) In silico design and search for acetylcholinesterase inhibitors in Alzheimer s disease with a suitable pharmacokinetic profile and low toxicity. Future Med Chem. 3:947-60.
5. Campo V. L., Kawano D. F., Silva Júnior D. B., Carvalho I. (2009) Carrageenans: biological properties, structural analysis and chemical modification. Carbohydr. Polym. 77:167-80.
6. Silva V. B., Kawano D. F., Carvalho I., Conceição E. C., Freitas O., Silva C. H. T. P. (2009) Psoralen and bergapten: in silico metabolism and toxicophoric analysis of drugs used to treat vitiligo. J. Pharm. Pharm. Sci. 12:378-87.
7. Kawano D. F., Ueta J., Sankarankutty A. K., Pereira L. R. L, Freitas O. (2009) Midazolam related drug interactions: detection of risk situations to the pati.ent safety in a Brazilian teaching Hospital. J. Patient Saf. 5:69-74.
8. Silva V. B., Kawano D. F., Gomes A. S., Carvalho I., Taft C. A., Silva C. H. T. P. (2008) Molecular dynamics, density functional, ADMET predictions, virtual screening, and molecular interaction field studies for identification and evaluation of novel potential CDK₂ inhibitors in cancer therapy. J. Phys. Chem. 112:8902-10.
9. Kawano D. F., Pereira L. R. L., Ueta J., Freitas O. (2007) Medication misadventures: how to minimize them? Braz. J. Pharm. Sci. 42:487-95.

Profile Details

Last Updated: November 21, 2013.

Reference this profile directly: Null